SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-026760
Filing Date
2024-02-07
Accepted
2024-02-07 16:52:11
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1/A d602978ds1a.htm S-1/A 2159418
2 EX-5.1 d602978dex51.htm EX-5.1 6724
3 EX-21.1 d602978dex211.htm EX-21.1 1871
4 EX-23.1 d602978dex231.htm EX-23.1 1531
5 EX-FILING FEES d602978dexfilingfees.htm EX-FILING FEES 38781
6 GRAPHIC g602978g0205185306051.jpg GRAPHIC 1915
7 GRAPHIC g602978g04g04.jpg GRAPHIC 33930
8 GRAPHIC g602978g04g06.jpg GRAPHIC 82160
9 GRAPHIC g602978g04g07.jpg GRAPHIC 64423
10 GRAPHIC g602978g04g08.jpg GRAPHIC 154300
11 GRAPHIC g602978g04g09.jpg GRAPHIC 72512
12 GRAPHIC g602978g04g10.jpg GRAPHIC 55301
13 GRAPHIC g602978g05g05.jpg GRAPHIC 78396
14 GRAPHIC g602978g34g34.jpg GRAPHIC 74456
  Complete submission text file 0001193125-24-026760.txt   3028953
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-274863 | Film No.: 24605010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)